| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/04/1994 | WO1994016715A1 Selective cell proliferation |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994012650A3 Activating expression of an amplifying endogenous gene by homologous recombination |
| 08/04/1994 | CA2154787A1 Selective cell proliferation |
| 08/04/1994 | CA2154468A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | CA2154363A1 Localization of therapeutic agents |
| 08/02/1994 | US5334711 Synthetic catalytic oligonucleotide structures |
| 08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/21/1994 | WO1994016073A2 Methods and reagents for inhibiting furin endoprotease |
| 07/21/1994 | WO1994016065A1 Producing cells for transplantation to reduce host rejection and resulting cells |
| 07/21/1994 | WO1994016059A1 Method for production of neuroblasts |
| 07/21/1994 | WO1994016057A1 Enhancer sequence for modulating expression in epithelial cells |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015646A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
| 07/21/1994 | WO1994015581A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | WO1994015466A1 Surrogate endocrine glands by genetic reassignment |
| 07/21/1994 | WO1994015459A1 Method for isolation and transplantation of specialized hepatocytes |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153158A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/21/1994 | CA2152597A1 Method for production of neuroblasts |
| 07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
| 07/21/1994 | CA2152379A1 Reduced and controlled surface binding of biologically active molecules |
| 07/20/1994 | EP0606376A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
| 07/13/1994 | EP0605466A1 Method and compositions for cellular reprogramming |
| 07/12/1994 | US5328470 Catheter |
| 07/08/1994 | CA2086844A1 Method and product of gene transfer into cells |
| 07/07/1994 | WO1994014956A1 Molecular flashlight |
| 07/07/1994 | WO1994014459A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 07/07/1994 | WO1994014347A1 A protective garment |
| 07/07/1994 | WO1993022433A3 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
| 07/06/1994 | EP0604560A1 Human cyclin e |
| 07/06/1994 | EP0604409A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/05/1994 | CA2112652A1 New transdominant tat variants for hiv virus |
| 06/28/1994 | US5324731 Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated |
| 06/28/1994 | US5324655 Human Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusions |
| 06/28/1994 | US5324654 Method for reversibly increasing proliferation of a non-malignant cell population |
| 06/28/1994 | US5324643 By interfering with one or more of the infection processes including retroviral replication and assembly into infective viral particles |
| 06/23/1994 | WO1994013824A1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 06/23/1994 | WO1994013823A1 Nucleotide sequence for treating cancer and infection |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013791A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 06/23/1994 | WO1994013788A1 Recombinant viral vector system |
| 06/23/1994 | CA2151496A1 Nucleotide sequence for treating cancer and infection |
| 06/23/1994 | CA2150536A1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 06/22/1994 | EP0602157A1 Ribosomal structure derived from the genomic rna structure of the delta hepatitus virus |
| 06/22/1994 | EP0602118A1 $i(IN VIVO) GENE TRANSFER USING IMPLANTED RETROVIRAL PRODUCER CELLS |
| 06/15/1994 | EP0600930A1 Diagnosis and treatment of autoimmune diseases |
| 06/14/1994 | US5321030 Administering for treatment or prevention |
| 06/14/1994 | US5320947 Immune reactivity to expressed activated oncogenes for diagnosis of malignancy |
| 06/09/1994 | WO1994012650A2 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | WO1994012649A2 Gene therapy for cystic fibrosis |
| 06/09/1994 | WO1994012629A1 Episomal vectors for gene therapy |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | WO1994012209A1 Malignant cell growth regulation by common acute lymphoblastic leukemia antigen |
| 06/09/1994 | CA2592997A1 Pseudo-adenovirus vectors |
| 06/09/1994 | CA2151032A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |
| 06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 06/08/1994 | EP0600278A2 Glutamate receptor protein and gene coding the same |
| 05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 05/26/1994 | WO1994011524A1 Targetable vector particles |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011494A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011011A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | WO1994008002A3 Methods and compositions for controlling translation of hcv proteins |
| 05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2148835A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | CA2148687A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen |
| 05/26/1994 | CA2083812A1 Expression vectors and their use in the preparation of hiv-resistant human cells for therapeutic applications |
| 05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
| 05/11/1994 | WO1994010323A1 Virus with modified binding moiety specific for the target cells |
| 05/11/1994 | WO1994010322A1 Adenovirus-mediated ldl receptor gene transfer and targeting |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010305A1 Transformed endothelial cells |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010292A1 Biological factors and neural stem cells |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994009828A1 Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1993024641A3 Adeno-associated virus with inverted terminal repeat sequences as promoter |